Ownership history in Squarepoint Ops LLC · 10 quarters on record
This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in CUE BIOPHARMA INC (CUE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 85,800 | +51,022 | +146.7% | 0.00% | $62K | $0.72 |
| 2025 Q1 | ADDED | 34,778 | +15,098 | +76.7% | 0.00% | $32K | $0.91 |
| 2024 Q4 | REDUCED | 19,680 | -37,638 | -65.7% | 0.00% | $21K | $1.09 |
| 2024 Q2 | REDUCED | 57,318 | -58,834 | -50.7% | 0.00% | $71K | $1.24 |
| 2024 Q1 | ADDED | 116,152 | +72,540 | +166.3% | 0.00% | $220K | $1.89 |
| 2023 Q4 | ADDED | 43,612 | +24,709 | +130.7% | 0.00% | $115K | $2.64 |
| 2023 Q3 | REDUCED | 18,903 | -1,330 | -6.6% | 0.00% | $43K | $2.30 |
| 2023 Q1 | REDUCED | 20,233 | -5,972 | -22.8% | 0.00% | $72K | $3.57 |
| 2020 Q4 | ADDED | 26,205 | +6,270 | +31.5% | 0.00% | $328K | $12.51 |
| 2020 Q3 | INITIATED | 19,935 | — | — | 0.00% | $300K | $15.05 |
As of 2025 Q4 — sorted by position size